In addition to only alleviating AD symptoms, cholinesterase inhibitors and N-methyl-D-aspartate antagonists are associated with adverse side effects (decreased appetite, diarrhea, dizziness, insomnia, and nausea) and drug interactions [31,38]. This evidence concerns the gene BCHE and Alzheimer disease.